| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stroke | 113 | 2024 | 9744 | 4.980 |
Why?
|
| Tomography, X-Ray Computed | 138 | 2023 | 20710 | 4.180 |
Why?
|
| Cerebral Angiography | 49 | 2021 | 1263 | 4.060 |
Why?
|
| Perfusion Imaging | 13 | 2023 | 193 | 3.390 |
Why?
|
| Brain Ischemia | 40 | 2024 | 3001 | 3.080 |
Why?
|
| Infarction, Middle Cerebral Artery | 13 | 2023 | 484 | 2.030 |
Why?
|
| Cerebrovascular Circulation | 36 | 2016 | 2671 | 1.870 |
Why?
|
| Cerebral Infarction | 12 | 2018 | 968 | 1.770 |
Why?
|
| Magnetic Resonance Imaging | 82 | 2024 | 36570 | 1.750 |
Why?
|
| Thrombolytic Therapy | 24 | 2020 | 2053 | 1.690 |
Why?
|
| Arterial Occlusive Diseases | 9 | 2023 | 742 | 1.430 |
Why?
|
| Carotid Stenosis | 13 | 2018 | 858 | 1.360 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 20 | 2021 | 2809 | 1.340 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 12 | 2015 | 1226 | 1.330 |
Why?
|
| Carotid Artery, Internal | 10 | 2018 | 440 | 1.300 |
Why?
|
| Angiography | 13 | 2022 | 1595 | 1.280 |
Why?
|
| Triage | 10 | 2021 | 995 | 1.280 |
Why?
|
| Brain Infarction | 7 | 2013 | 285 | 1.150 |
Why?
|
| Contrast Media | 37 | 2019 | 5329 | 1.090 |
Why?
|
| Intracranial Hemorrhages | 9 | 2023 | 810 | 1.010 |
Why?
|
| Magnetic Resonance Angiography | 13 | 2016 | 1428 | 0.940 |
Why?
|
| Head | 9 | 2023 | 926 | 0.940 |
Why?
|
| Endovascular Procedures | 12 | 2024 | 2215 | 0.920 |
Why?
|
| Tissue Plasminogen Activator | 12 | 2018 | 1164 | 0.900 |
Why?
|
| Cerebral Hemorrhage | 15 | 2018 | 2654 | 0.870 |
Why?
|
| Radiographic Image Enhancement | 9 | 2012 | 873 | 0.860 |
Why?
|
| Blood Volume | 9 | 2006 | 544 | 0.850 |
Why?
|
| Vascular System Injuries | 2 | 2023 | 247 | 0.820 |
Why?
|
| Dielectric Spectroscopy | 2 | 2013 | 30 | 0.820 |
Why?
|
| Carotid Arteries | 5 | 2018 | 932 | 0.810 |
Why?
|
| Brain | 61 | 2024 | 27158 | 0.810 |
Why?
|
| Brain Diseases | 10 | 2024 | 1552 | 0.800 |
Why?
|
| Anniversaries and Special Events | 1 | 2022 | 97 | 0.780 |
Why?
|
| Thrombectomy | 10 | 2023 | 676 | 0.770 |
Why?
|
| Blast Injuries | 2 | 2016 | 318 | 0.770 |
Why?
|
| Sensitivity and Specificity | 44 | 2018 | 14653 | 0.720 |
Why?
|
| Intracranial Thrombosis | 3 | 2008 | 109 | 0.710 |
Why?
|
| Algorithms | 17 | 2023 | 14073 | 0.700 |
Why?
|
| Image Processing, Computer-Assisted | 12 | 2021 | 8928 | 0.700 |
Why?
|
| Fibrinolytic Agents | 12 | 2018 | 2078 | 0.690 |
Why?
|
| Acute Disease | 33 | 2019 | 7240 | 0.680 |
Why?
|
| Neck Injuries | 3 | 2015 | 162 | 0.660 |
Why?
|
| Weightlessness | 1 | 2020 | 103 | 0.650 |
Why?
|
| Humans | 323 | 2024 | 766812 | 0.650 |
Why?
|
| Tomography, Spiral Computed | 5 | 2014 | 273 | 0.640 |
Why?
|
| Diagnostic Imaging | 11 | 2020 | 3530 | 0.610 |
Why?
|
| Leukoencephalopathies | 2 | 2021 | 258 | 0.610 |
Why?
|
| Deafness | 1 | 2022 | 460 | 0.610 |
Why?
|
| Craniocerebral Trauma | 4 | 2015 | 493 | 0.600 |
Why?
|
| Artificial Intelligence | 7 | 2022 | 2662 | 0.590 |
Why?
|
| Tomography Scanners, X-Ray Computed | 3 | 2009 | 170 | 0.590 |
Why?
|
| Gadolinium | 6 | 2016 | 964 | 0.590 |
Why?
|
| Space Flight | 1 | 2020 | 219 | 0.560 |
Why?
|
| Emergency Service, Hospital | 17 | 2024 | 7870 | 0.550 |
Why?
|
| Radiography, Dual-Energy Scanned Projection | 3 | 2016 | 208 | 0.530 |
Why?
|
| Vertebrobasilar Insufficiency | 3 | 2008 | 111 | 0.520 |
Why?
|
| Aged | 125 | 2024 | 171344 | 0.510 |
Why?
|
| Terrorism | 2 | 2016 | 211 | 0.500 |
Why?
|
| Image Interpretation, Computer-Assisted | 10 | 2020 | 3360 | 0.490 |
Why?
|
| Reperfusion | 3 | 2020 | 268 | 0.460 |
Why?
|
| Male | 183 | 2024 | 364154 | 0.450 |
Why?
|
| Aged, 80 and over | 73 | 2021 | 59548 | 0.450 |
Why?
|
| Brain Neoplasms | 14 | 2010 | 9101 | 0.450 |
Why?
|
| Cerebral Revascularization | 2 | 2013 | 260 | 0.440 |
Why?
|
| Patient Selection | 6 | 2019 | 4252 | 0.440 |
Why?
|
| Middle Cerebral Artery | 6 | 2013 | 271 | 0.440 |
Why?
|
| Neurofibromatosis 2 | 6 | 2009 | 387 | 0.440 |
Why?
|
| Paresis | 3 | 2012 | 177 | 0.440 |
Why?
|
| Image Enhancement | 9 | 2014 | 2858 | 0.440 |
Why?
|
| Reproducibility of Results | 30 | 2016 | 20146 | 0.430 |
Why?
|
| Multiple Trauma | 1 | 2016 | 369 | 0.420 |
Why?
|
| Retrospective Studies | 65 | 2024 | 81657 | 0.420 |
Why?
|
| Female | 171 | 2024 | 396532 | 0.410 |
Why?
|
| Middle Aged | 120 | 2024 | 223267 | 0.410 |
Why?
|
| Basilar Artery | 4 | 2009 | 207 | 0.410 |
Why?
|
| Radiation Injuries | 4 | 2010 | 1195 | 0.400 |
Why?
|
| Neuroradiography | 4 | 2019 | 71 | 0.390 |
Why?
|
| Regional Blood Flow | 6 | 2008 | 1478 | 0.390 |
Why?
|
| Aphasia | 2 | 2010 | 193 | 0.380 |
Why?
|
| Patient Admission | 3 | 2018 | 1364 | 0.380 |
Why?
|
| Perfusion | 7 | 2023 | 1409 | 0.370 |
Why?
|
| Heart Conduction System | 14 | 1994 | 1008 | 0.370 |
Why?
|
| Foreign Bodies | 1 | 2015 | 403 | 0.360 |
Why?
|
| ROC Curve | 8 | 2013 | 3621 | 0.340 |
Why?
|
| Software | 5 | 2021 | 4464 | 0.340 |
Why?
|
| Acute Kidney Injury | 2 | 2021 | 1946 | 0.340 |
Why?
|
| Cerebrovascular Disorders | 5 | 2009 | 1478 | 0.330 |
Why?
|
| Radiology Department, Hospital | 3 | 2019 | 409 | 0.330 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 4 | 2013 | 101 | 0.330 |
Why?
|
| Ischemic Attack, Transient | 5 | 2013 | 874 | 0.320 |
Why?
|
| Glioma | 4 | 2010 | 3498 | 0.310 |
Why?
|
| Heart Arrest | 1 | 2018 | 1516 | 0.300 |
Why?
|
| Blood Flow Velocity | 6 | 2006 | 1374 | 0.300 |
Why?
|
| Imaging, Three-Dimensional | 5 | 2017 | 4047 | 0.300 |
Why?
|
| Intensive Care Units | 2 | 2021 | 3799 | 0.300 |
Why?
|
| Cerebral Arteries | 6 | 2018 | 490 | 0.300 |
Why?
|
| Adult | 94 | 2024 | 223305 | 0.300 |
Why?
|
| Vitamin K Deficiency | 2 | 2007 | 24 | 0.300 |
Why?
|
| Opioid-Related Disorders | 2 | 2023 | 2188 | 0.290 |
Why?
|
| Subtraction Technique | 2 | 2010 | 514 | 0.290 |
Why?
|
| Radiation Dosage | 4 | 2011 | 1958 | 0.290 |
Why?
|
| 4-Hydroxycoumarins | 1 | 2007 | 2 | 0.280 |
Why?
|
| Artifacts | 6 | 2023 | 1897 | 0.280 |
Why?
|
| Radiography | 12 | 2022 | 6968 | 0.280 |
Why?
|
| Circle of Willis | 3 | 2004 | 77 | 0.270 |
Why?
|
| Hippocampus | 2 | 2020 | 3776 | 0.270 |
Why?
|
| Intestinal Obstruction | 2 | 2021 | 433 | 0.270 |
Why?
|
| Extremities | 1 | 2012 | 869 | 0.270 |
Why?
|
| Predictive Value of Tests | 22 | 2016 | 15425 | 0.270 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2013 | 1457 | 0.260 |
Why?
|
| Evidence-Based Medicine | 3 | 2013 | 3692 | 0.260 |
Why?
|
| Time Factors | 26 | 2020 | 40149 | 0.260 |
Why?
|
| Diffusion | 4 | 2013 | 808 | 0.260 |
Why?
|
| Fentanyl | 2 | 2020 | 451 | 0.250 |
Why?
|
| Observer Variation | 11 | 2013 | 2614 | 0.250 |
Why?
|
| Severity of Illness Index | 17 | 2021 | 15912 | 0.250 |
Why?
|
| Echo-Planar Imaging | 4 | 2022 | 649 | 0.250 |
Why?
|
| Neck | 2 | 2019 | 736 | 0.240 |
Why?
|
| Brain Injuries | 3 | 2021 | 2053 | 0.240 |
Why?
|
| Heart Block | 8 | 1997 | 391 | 0.240 |
Why?
|
| Diagnosis, Differential | 18 | 2021 | 12985 | 0.240 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 2 | 2020 | 551 | 0.240 |
Why?
|
| Trauma Centers | 2 | 2024 | 950 | 0.240 |
Why?
|
| Ink | 1 | 2024 | 46 | 0.230 |
Why?
|
| Atrioventricular Node | 10 | 1995 | 180 | 0.230 |
Why?
|
| Neoplasm Recurrence, Local | 5 | 2010 | 9407 | 0.230 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2012 | 996 | 0.230 |
Why?
|
| American Heart Association | 2 | 2024 | 1049 | 0.230 |
Why?
|
| Electric Conductivity | 1 | 2024 | 405 | 0.220 |
Why?
|
| Polymers | 2 | 2024 | 1624 | 0.220 |
Why?
|
| Sulfoglycosphingolipids | 2 | 1996 | 32 | 0.220 |
Why?
|
| Models, Cardiovascular | 1 | 2009 | 978 | 0.210 |
Why?
|
| Whole Body Imaging | 2 | 2022 | 283 | 0.210 |
Why?
|
| Blood Vessels | 1 | 2009 | 1111 | 0.210 |
Why?
|
| Hematoma | 4 | 2010 | 766 | 0.200 |
Why?
|
| Prospective Studies | 27 | 2024 | 54872 | 0.200 |
Why?
|
| Aluminum | 1 | 2023 | 150 | 0.200 |
Why?
|
| Spinal Cord Compression | 1 | 2024 | 234 | 0.200 |
Why?
|
| Elder Abuse | 1 | 2022 | 36 | 0.200 |
Why?
|
| Thorax | 2 | 2022 | 555 | 0.200 |
Why?
|
| Oligodendroglioma | 1 | 2004 | 274 | 0.200 |
Why?
|
| Radiometry | 3 | 2023 | 814 | 0.200 |
Why?
|
| Safety | 3 | 2021 | 1157 | 0.200 |
Why?
|
| Motor Activity | 1 | 2012 | 2711 | 0.200 |
Why?
|
| Boston | 8 | 2019 | 9346 | 0.190 |
Why?
|
| Neoplasms, Neuroepithelial | 1 | 2002 | 43 | 0.190 |
Why?
|
| Subarachnoid Hemorrhage | 3 | 2010 | 1023 | 0.190 |
Why?
|
| Potassium | 1 | 2006 | 1314 | 0.190 |
Why?
|
| Infarction | 1 | 2023 | 247 | 0.190 |
Why?
|
| Treatment Outcome | 23 | 2023 | 65286 | 0.190 |
Why?
|
| Radiology Information Systems | 4 | 2017 | 535 | 0.190 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 1 | 2022 | 256 | 0.190 |
Why?
|
| Vitamin K | 3 | 2007 | 314 | 0.190 |
Why?
|
| Blood-Brain Barrier | 2 | 2006 | 1028 | 0.190 |
Why?
|
| Utilization Review | 2 | 2021 | 381 | 0.190 |
Why?
|
| Prognosis | 19 | 2016 | 29959 | 0.180 |
Why?
|
| United States Food and Drug Administration | 1 | 2009 | 1673 | 0.180 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2010 | 2028 | 0.180 |
Why?
|
| Nervous System Diseases | 4 | 2020 | 1659 | 0.180 |
Why?
|
| Computer Simulation | 6 | 2021 | 6258 | 0.180 |
Why?
|
| Neurocysticercosis | 1 | 2021 | 91 | 0.170 |
Why?
|
| Radiology | 4 | 2022 | 2105 | 0.170 |
Why?
|
| Oxygen | 2 | 2022 | 4252 | 0.170 |
Why?
|
| Meningioma | 3 | 2007 | 1221 | 0.170 |
Why?
|
| Cognitive Reserve | 1 | 2020 | 92 | 0.170 |
Why?
|
| Amnesia | 2 | 2020 | 257 | 0.170 |
Why?
|
| Necrosis | 6 | 2010 | 1614 | 0.160 |
Why?
|
| Hyoid Bone | 1 | 1999 | 38 | 0.160 |
Why?
|
| Communication Barriers | 1 | 2023 | 418 | 0.160 |
Why?
|
| Rest | 2 | 2024 | 940 | 0.160 |
Why?
|
| Wounds, Nonpenetrating | 2 | 2010 | 807 | 0.160 |
Why?
|
| Astrocytoma | 1 | 2004 | 773 | 0.160 |
Why?
|
| Empathy | 1 | 2023 | 474 | 0.160 |
Why?
|
| Severe Acute Respiratory Syndrome | 1 | 2020 | 136 | 0.160 |
Why?
|
| Xenon | 1 | 1999 | 120 | 0.160 |
Why?
|
| Intracranial Arteriosclerosis | 2 | 2014 | 138 | 0.160 |
Why?
|
| Pilot Projects | 7 | 2021 | 8728 | 0.160 |
Why?
|
| Cerebral Cortex | 5 | 2020 | 5753 | 0.160 |
Why?
|
| Pattern Recognition, Automated | 2 | 2018 | 980 | 0.150 |
Why?
|
| Meningeal Neoplasms | 2 | 2006 | 1255 | 0.150 |
Why?
|
| Diverticulitis | 1 | 2021 | 187 | 0.150 |
Why?
|
| Databases as Topic | 2 | 2018 | 472 | 0.150 |
Why?
|
| Multivariate Analysis | 7 | 2014 | 12064 | 0.150 |
Why?
|
| Collateral Circulation | 3 | 2021 | 289 | 0.150 |
Why?
|
| Workflow | 2 | 2022 | 859 | 0.150 |
Why?
|
| Hydromorphone | 1 | 2018 | 70 | 0.150 |
Why?
|
| Adenoma, Pleomorphic | 1 | 1998 | 77 | 0.150 |
Why?
|
| Bundle of His | 10 | 1995 | 102 | 0.150 |
Why?
|
| Injections, Intra-Arterial | 3 | 2013 | 181 | 0.150 |
Why?
|
| Intestinal Perforation | 1 | 2019 | 254 | 0.150 |
Why?
|
| Amphetamines | 1 | 2018 | 142 | 0.140 |
Why?
|
| Fractures, Closed | 1 | 2018 | 88 | 0.140 |
Why?
|
| Night Care | 1 | 2017 | 28 | 0.140 |
Why?
|
| Emergency Medical Services | 3 | 2016 | 1936 | 0.140 |
Why?
|
| Cranial Nerve Neoplasms | 2 | 2009 | 131 | 0.140 |
Why?
|
| Fatal Outcome | 4 | 2018 | 1838 | 0.140 |
Why?
|
| Multiple Sclerosis, Chronic Progressive | 1 | 2000 | 253 | 0.140 |
Why?
|
| Depression | 1 | 2017 | 8225 | 0.140 |
Why?
|
| Post-Concussion Syndrome | 1 | 2020 | 257 | 0.140 |
Why?
|
| Leukoencephalopathy, Progressive Multifocal | 1 | 2018 | 133 | 0.140 |
Why?
|
| Time Management | 1 | 2017 | 53 | 0.140 |
Why?
|
| Pentetic Acid | 1 | 1997 | 209 | 0.140 |
Why?
|
| Brain Edema | 1 | 2021 | 601 | 0.140 |
Why?
|
| Parotid Neoplasms | 1 | 1998 | 158 | 0.140 |
Why?
|
| Intracranial Aneurysm | 4 | 2001 | 1271 | 0.140 |
Why?
|
| Larynx | 2 | 2000 | 492 | 0.140 |
Why?
|
| Vasospasm, Intracranial | 2 | 2010 | 207 | 0.140 |
Why?
|
| Organometallic Compounds | 2 | 2016 | 647 | 0.130 |
Why?
|
| Microvessels | 1 | 2021 | 586 | 0.130 |
Why?
|
| Magnetoencephalography | 1 | 2000 | 585 | 0.130 |
Why?
|
| Carotid Artery Diseases | 3 | 2018 | 872 | 0.130 |
Why?
|
| Foot Injuries | 1 | 2018 | 154 | 0.130 |
Why?
|
| Neuroma, Acoustic | 3 | 2009 | 456 | 0.130 |
Why?
|
| Iopamidol | 3 | 2019 | 188 | 0.130 |
Why?
|
| Ambulatory Care Facilities | 1 | 2022 | 939 | 0.130 |
Why?
|
| Systems Analysis | 1 | 2017 | 168 | 0.130 |
Why?
|
| Iodine | 3 | 2017 | 285 | 0.130 |
Why?
|
| Catheterization, Peripheral | 2 | 2018 | 346 | 0.130 |
Why?
|
| Anticoagulants | 3 | 2010 | 4854 | 0.130 |
Why?
|
| Epidural Abscess | 1 | 2017 | 94 | 0.130 |
Why?
|
| Analgesics, Opioid | 2 | 2023 | 3837 | 0.130 |
Why?
|
| Disease Progression | 11 | 2021 | 13642 | 0.130 |
Why?
|
| Radiography, Thoracic | 3 | 2021 | 1320 | 0.120 |
Why?
|
| Medicine | 1 | 2023 | 944 | 0.120 |
Why?
|
| Heart Ventricles | 16 | 2019 | 3831 | 0.120 |
Why?
|
| Explosions | 1 | 2016 | 106 | 0.120 |
Why?
|
| Logistic Models | 5 | 2013 | 13276 | 0.120 |
Why?
|
| Cysts | 1 | 2000 | 685 | 0.120 |
Why?
|
| Inpatients | 2 | 2024 | 2566 | 0.120 |
Why?
|
| Mental Recall | 1 | 2021 | 1218 | 0.120 |
Why?
|
| Anti-Obesity Agents | 1 | 2018 | 241 | 0.120 |
Why?
|
| Cerebral Veins | 2 | 2011 | 157 | 0.120 |
Why?
|
| Myelinolysis, Central Pontine | 1 | 2014 | 17 | 0.120 |
Why?
|
| Cranial Fossa, Posterior | 2 | 2014 | 134 | 0.120 |
Why?
|
| Appendicitis | 1 | 2021 | 680 | 0.120 |
Why?
|
| Efficiency | 1 | 2017 | 479 | 0.110 |
Why?
|
| Phlebography | 2 | 2010 | 326 | 0.110 |
Why?
|
| Medical Order Entry Systems | 1 | 2019 | 523 | 0.110 |
Why?
|
| Water | 1 | 2020 | 1416 | 0.110 |
Why?
|
| Hospital Mortality | 4 | 2013 | 5344 | 0.110 |
Why?
|
| Patient Care | 1 | 2020 | 629 | 0.110 |
Why?
|
| Calcinosis | 2 | 2016 | 1480 | 0.110 |
Why?
|
| Electroencephalography | 3 | 2024 | 6282 | 0.110 |
Why?
|
| Pulmonary Artery | 6 | 2019 | 1938 | 0.110 |
Why?
|
| Ankle Injuries | 1 | 2018 | 339 | 0.110 |
Why?
|
| Cohort Studies | 14 | 2017 | 41706 | 0.110 |
Why?
|
| Urolithiasis | 1 | 2015 | 123 | 0.110 |
Why?
|
| Finite Element Analysis | 1 | 2016 | 441 | 0.110 |
Why?
|
| Substance-Related Disorders | 2 | 2021 | 4421 | 0.110 |
Why?
|
| Gastrointestinal Agents | 1 | 2018 | 511 | 0.110 |
Why?
|
| Nerve Tissue | 1 | 2013 | 77 | 0.110 |
Why?
|
| Intestine, Small | 1 | 2019 | 1217 | 0.110 |
Why?
|
| Warfarin | 3 | 2010 | 1493 | 0.110 |
Why?
|
| Mesonephroma | 1 | 1993 | 21 | 0.110 |
Why?
|
| Mass Casualty Incidents | 1 | 2016 | 178 | 0.110 |
Why?
|
| Positron-Emission Tomography | 1 | 2010 | 6548 | 0.110 |
Why?
|
| Single-Blind Method | 2 | 2014 | 1587 | 0.110 |
Why?
|
| Catheterization, Central Venous | 1 | 2018 | 538 | 0.110 |
Why?
|
| Cholesteatoma | 1 | 2013 | 28 | 0.110 |
Why?
|
| Radio Waves | 3 | 1989 | 245 | 0.110 |
Why?
|
| Child | 40 | 2023 | 80670 | 0.110 |
Why?
|
| Heart Septal Defects, Atrial | 6 | 1983 | 452 | 0.100 |
Why?
|
| Emergencies | 2 | 2019 | 1223 | 0.100 |
Why?
|
| Edema | 1 | 2017 | 764 | 0.100 |
Why?
|
| Scalp | 1 | 2016 | 390 | 0.100 |
Why?
|
| Peer Review | 1 | 2015 | 218 | 0.100 |
Why?
|
| Diplopia | 1 | 2014 | 217 | 0.100 |
Why?
|
| Cerebral Arterial Diseases | 1 | 2013 | 82 | 0.100 |
Why?
|
| Transducers | 1 | 2014 | 238 | 0.100 |
Why?
|
| Neurology | 2 | 2013 | 785 | 0.100 |
Why?
|
| Adolescent | 39 | 2018 | 88902 | 0.100 |
Why?
|
| Follow-Up Studies | 13 | 2017 | 39312 | 0.100 |
Why?
|
| Mesentery | 1 | 1993 | 201 | 0.100 |
Why?
|
| Waiting Lists | 1 | 2017 | 779 | 0.100 |
Why?
|
| Dominance, Cerebral | 2 | 2004 | 616 | 0.100 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2018 | 783 | 0.100 |
Why?
|
| Hematoma, Subdural | 1 | 2013 | 128 | 0.100 |
Why?
|
| Diagnostic Errors | 1 | 1999 | 1276 | 0.100 |
Why?
|
| Electrocoagulation | 2 | 1989 | 156 | 0.100 |
Why?
|
| Risk Management | 1 | 2015 | 558 | 0.100 |
Why?
|
| Heart Defects, Congenital | 14 | 1982 | 4712 | 0.100 |
Why?
|
| HN Protein | 2 | 2001 | 8 | 0.100 |
Why?
|
| Clinical Trials as Topic | 3 | 2013 | 8045 | 0.100 |
Why?
|
| Pneumonia | 2 | 2013 | 2161 | 0.100 |
Why?
|
| Massachusetts | 5 | 2021 | 8890 | 0.100 |
Why?
|
| Myocardium | 12 | 1997 | 4765 | 0.100 |
Why?
|
| Young Adult | 17 | 2023 | 59939 | 0.100 |
Why?
|
| Tricuspid Valve | 7 | 1981 | 419 | 0.090 |
Why?
|
| Heart Septum | 4 | 1995 | 304 | 0.090 |
Why?
|
| Infusions, Intravenous | 2 | 2013 | 2228 | 0.090 |
Why?
|
| Infusions, Intra-Arterial | 2 | 2008 | 220 | 0.090 |
Why?
|
| Causality | 4 | 2013 | 1252 | 0.090 |
Why?
|
| Transposition of Great Vessels | 9 | 1994 | 581 | 0.090 |
Why?
|
| Neurilemmoma | 2 | 2007 | 522 | 0.090 |
Why?
|
| Heart Atria | 9 | 2001 | 1362 | 0.090 |
Why?
|
| Running | 1 | 2016 | 488 | 0.090 |
Why?
|
| Headache | 5 | 2024 | 1260 | 0.090 |
Why?
|
| Periodicals as Topic | 2 | 2015 | 1463 | 0.090 |
Why?
|
| Electrocardiography | 14 | 2018 | 6408 | 0.090 |
Why?
|
| Osteolysis | 1 | 1992 | 273 | 0.090 |
Why?
|
| Endarterectomy, Carotid | 3 | 2008 | 556 | 0.090 |
Why?
|
| Practice Guidelines as Topic | 3 | 2013 | 7430 | 0.090 |
Why?
|
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 | 2014 | 238 | 0.090 |
Why?
|
| Tachycardia, Ectopic Atrial | 1 | 1991 | 65 | 0.090 |
Why?
|
| Otitis Media | 1 | 2013 | 287 | 0.090 |
Why?
|
| Stochastic Processes | 1 | 2012 | 359 | 0.090 |
Why?
|
| Medicare | 3 | 2023 | 6813 | 0.090 |
Why?
|
| Antiphospholipid Syndrome | 1 | 1992 | 166 | 0.090 |
Why?
|
| Polyethylenes | 1 | 1992 | 294 | 0.090 |
Why?
|
| Putamen | 1 | 2011 | 288 | 0.090 |
Why?
|
| Case-Control Studies | 4 | 2017 | 22248 | 0.090 |
Why?
|
| Child, Preschool | 31 | 2023 | 42577 | 0.090 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2016 | 708 | 0.080 |
Why?
|
| Hemagglutinin Glycoproteins, Influenza Virus | 2 | 2001 | 163 | 0.080 |
Why?
|
| Cerebral Hemorrhage, Traumatic | 1 | 2009 | 20 | 0.080 |
Why?
|
| Area Under Curve | 2 | 2011 | 1639 | 0.080 |
Why?
|
| Statistics as Topic | 2 | 2008 | 2350 | 0.080 |
Why?
|
| Seizures | 2 | 2021 | 2996 | 0.080 |
Why?
|
| Comorbidity | 7 | 2014 | 10580 | 0.080 |
Why?
|
| Caudate Nucleus | 1 | 2011 | 388 | 0.080 |
Why?
|
| Dogs | 10 | 1995 | 3834 | 0.080 |
Why?
|
| Pandemics | 4 | 2023 | 8734 | 0.080 |
Why?
|
| Intracranial Arterial Diseases | 1 | 2009 | 22 | 0.080 |
Why?
|
| Hematoma, Subdural, Intracranial | 1 | 2009 | 30 | 0.080 |
Why?
|
| Consciousness Disorders | 2 | 2021 | 445 | 0.080 |
Why?
|
| Radiation Injuries, Experimental | 1 | 1989 | 88 | 0.080 |
Why?
|
| History, 20th Century | 2 | 2009 | 2764 | 0.080 |
Why?
|
| Radiotherapy | 2 | 2010 | 1497 | 0.080 |
Why?
|
| Head Injuries, Closed | 1 | 2010 | 133 | 0.080 |
Why?
|
| Radiology, Interventional | 1 | 2013 | 483 | 0.080 |
Why?
|
| Sinus Thrombosis, Intracranial | 1 | 2010 | 111 | 0.080 |
Why?
|
| Kidney Diseases | 2 | 2010 | 2101 | 0.080 |
Why?
|
| Nicardipine | 1 | 2008 | 59 | 0.080 |
Why?
|
| Feasibility Studies | 6 | 2020 | 5306 | 0.080 |
Why?
|
| Skull Fractures | 1 | 2010 | 202 | 0.080 |
Why?
|
| Bayes Theorem | 1 | 2017 | 2353 | 0.080 |
Why?
|
| Ultrasonography, Doppler | 2 | 2002 | 464 | 0.080 |
Why?
|
| Hospitals, General | 1 | 2013 | 804 | 0.080 |
Why?
|
| Electrosurgery | 1 | 1988 | 53 | 0.080 |
Why?
|
| Chi-Square Distribution | 2 | 2011 | 3431 | 0.080 |
Why?
|
| Spin Labels | 1 | 2010 | 334 | 0.080 |
Why?
|
| Nerve Net | 1 | 2020 | 2307 | 0.080 |
Why?
|
| Temporal Bone | 1 | 2013 | 683 | 0.080 |
Why?
|
| Neoplasms | 3 | 2023 | 22350 | 0.070 |
Why?
|
| Cerebrosides | 1 | 1987 | 7 | 0.070 |
Why?
|
| Radiation Protection | 1 | 2011 | 425 | 0.070 |
Why?
|
| Leukoaraiosis | 1 | 2009 | 114 | 0.070 |
Why?
|
| Trauma Severity Indices | 1 | 2009 | 479 | 0.070 |
Why?
|
| Ultrasonography, Doppler, Duplex | 1 | 2008 | 198 | 0.070 |
Why?
|
| Electroshock | 2 | 1985 | 120 | 0.070 |
Why?
|
| Uncertainty | 2 | 2023 | 765 | 0.070 |
Why?
|
| Reference Standards | 2 | 2009 | 1010 | 0.070 |
Why?
|
| Lumbar Vertebrae | 1 | 2017 | 1878 | 0.070 |
Why?
|
| Hematemesis | 1 | 2007 | 22 | 0.070 |
Why?
|
| United States | 14 | 2024 | 72945 | 0.070 |
Why?
|
| Coronary Vessels | 4 | 1994 | 3115 | 0.070 |
Why?
|
| Sphingolipids | 1 | 1988 | 177 | 0.070 |
Why?
|
| Cycloserine | 1 | 1987 | 118 | 0.070 |
Why?
|
| Gaucher Disease | 1 | 1987 | 110 | 0.070 |
Why?
|
| Heart Septal Defects, Ventricular | 8 | 1981 | 477 | 0.070 |
Why?
|
| Prothrombin Time | 1 | 2007 | 117 | 0.070 |
Why?
|
| Hip Prosthesis | 1 | 1992 | 924 | 0.070 |
Why?
|
| Disease Management | 1 | 2017 | 2533 | 0.070 |
Why?
|
| Risk Factors | 11 | 2013 | 74889 | 0.070 |
Why?
|
| Prevalence | 5 | 2022 | 15835 | 0.070 |
Why?
|
| Peritoneal Neoplasms | 1 | 1993 | 706 | 0.070 |
Why?
|
| Crowding | 2 | 2018 | 142 | 0.070 |
Why?
|
| Age Distribution | 2 | 2009 | 2869 | 0.070 |
Why?
|
| Phantoms, Imaging | 3 | 2024 | 2474 | 0.070 |
Why?
|
| Partial Thromboplastin Time | 1 | 2007 | 203 | 0.060 |
Why?
|
| Epistaxis | 1 | 2007 | 117 | 0.060 |
Why?
|
| Risk Assessment | 6 | 2018 | 24299 | 0.060 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 1993 | 790 | 0.060 |
Why?
|
| Technology, Radiologic | 1 | 2006 | 158 | 0.060 |
Why?
|
| Tricuspid Valve Prolapse | 1 | 1985 | 6 | 0.060 |
Why?
|
| Research Design | 2 | 2013 | 6206 | 0.060 |
Why?
|
| Death, Sudden, Cardiac | 1 | 1994 | 1567 | 0.060 |
Why?
|
| Abdomen | 2 | 2022 | 1137 | 0.060 |
Why?
|
| Pulmonary Embolism | 1 | 2019 | 2596 | 0.060 |
Why?
|
| Tomography, Emission-Computed | 1 | 2008 | 1006 | 0.060 |
Why?
|
| Thrombosis | 2 | 2007 | 2953 | 0.060 |
Why?
|
| Radiopharmaceuticals | 2 | 2010 | 2703 | 0.060 |
Why?
|
| Clinical Protocols | 3 | 2024 | 1438 | 0.060 |
Why?
|
| Poisoning | 1 | 2007 | 254 | 0.060 |
Why?
|
| Ductus Arteriosus, Patent | 4 | 1982 | 216 | 0.060 |
Why?
|
| Transportation of Patients | 1 | 2006 | 177 | 0.060 |
Why?
|
| Iohexol | 1 | 2006 | 205 | 0.060 |
Why?
|
| Receptors, Immunologic | 2 | 2001 | 1417 | 0.060 |
Why?
|
| Blood Volume Determination | 1 | 2004 | 41 | 0.060 |
Why?
|
| Unconsciousness | 1 | 2007 | 252 | 0.060 |
Why?
|
| Emergency Treatment | 1 | 2008 | 495 | 0.060 |
Why?
|
| Endocardial Fibroelastosis | 3 | 1982 | 66 | 0.060 |
Why?
|
| Cross Infection | 1 | 2013 | 1427 | 0.060 |
Why?
|
| Hemorrhage | 2 | 2016 | 3464 | 0.060 |
Why?
|
| Bibliometrics | 1 | 2008 | 355 | 0.060 |
Why?
|
| Catheter Ablation | 3 | 1995 | 2787 | 0.060 |
Why?
|
| Pesticides | 1 | 2007 | 297 | 0.060 |
Why?
|
| Language | 2 | 2023 | 1550 | 0.060 |
Why?
|
| Demography | 2 | 2014 | 1641 | 0.050 |
Why?
|
| Early Diagnosis | 3 | 2016 | 1186 | 0.050 |
Why?
|
| Consensus | 1 | 2013 | 3208 | 0.050 |
Why?
|
| Glioblastoma | 3 | 2006 | 3458 | 0.050 |
Why?
|
| Gadolinium DTPA | 3 | 2016 | 823 | 0.050 |
Why?
|
| Telemedicine | 1 | 2021 | 3111 | 0.050 |
Why?
|
| Electrophysiology | 5 | 1992 | 1263 | 0.050 |
Why?
|
| Iodine Compounds | 1 | 2003 | 28 | 0.050 |
Why?
|
| Orthomyxoviridae | 2 | 2001 | 148 | 0.050 |
Why?
|
| Health Policy | 1 | 2015 | 2697 | 0.050 |
Why?
|
| Critical Care | 1 | 2016 | 2714 | 0.050 |
Why?
|
| Head and Neck Neoplasms | 3 | 2019 | 2930 | 0.050 |
Why?
|
| Health Expenditures | 1 | 2015 | 2389 | 0.050 |
Why?
|
| Vasculitis | 1 | 2007 | 528 | 0.050 |
Why?
|
| Wakefulness | 1 | 2010 | 1282 | 0.050 |
Why?
|
| Mice, Inbred ICR | 2 | 1996 | 361 | 0.050 |
Why?
|
| Equipment Design | 4 | 2020 | 3488 | 0.050 |
Why?
|
| Tachycardia, Paroxysmal | 1 | 1982 | 30 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3110 | 0.050 |
Why?
|
| Adipose Tissue | 2 | 2013 | 3317 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3232 | 0.050 |
Why?
|
| Neuroschistosomiasis | 1 | 2001 | 3 | 0.050 |
Why?
|
| Time | 1 | 2024 | 550 | 0.050 |
Why?
|
| Aortic Valve Stenosis | 3 | 1989 | 2023 | 0.050 |
Why?
|
| Hearing Loss | 1 | 2009 | 785 | 0.050 |
Why?
|
| Models, Neurological | 1 | 2010 | 1747 | 0.050 |
Why?
|
| Killer Cells, Natural | 2 | 2001 | 2209 | 0.050 |
Why?
|
| Diabetes Complications | 1 | 2008 | 1319 | 0.050 |
Why?
|
| Infant | 27 | 2014 | 36459 | 0.050 |
Why?
|
| Hodgkin Disease | 2 | 1998 | 1384 | 0.050 |
Why?
|
| Aortic Coarctation | 3 | 1982 | 278 | 0.050 |
Why?
|
| Parasitic Diseases | 1 | 2021 | 76 | 0.050 |
Why?
|
| Lymphatic Diseases | 2 | 2000 | 318 | 0.050 |
Why?
|
| Creatine | 1 | 2023 | 424 | 0.050 |
Why?
|
| Brain Mapping | 3 | 2010 | 6597 | 0.050 |
Why?
|
| Swine | 1 | 1991 | 5985 | 0.050 |
Why?
|
| X-Rays | 1 | 2022 | 309 | 0.050 |
Why?
|
| Age Factors | 7 | 2012 | 18397 | 0.050 |
Why?
|
| Myxoma | 1 | 2001 | 114 | 0.050 |
Why?
|
| Numerical Analysis, Computer-Assisted | 1 | 2001 | 120 | 0.050 |
Why?
|
| Branchioma | 1 | 2000 | 17 | 0.050 |
Why?
|
| Cytotoxicity, Immunologic | 2 | 2001 | 1352 | 0.040 |
Why?
|
| Thyroglossal Cyst | 1 | 2000 | 31 | 0.040 |
Why?
|
| Truncus Arteriosus, Persistent | 1 | 1981 | 63 | 0.040 |
Why?
|
| Mediastinal Cyst | 1 | 2000 | 30 | 0.040 |
Why?
|
| Corpus Callosum | 1 | 2005 | 751 | 0.040 |
Why?
|
| Sinoatrial Node | 3 | 1991 | 99 | 0.040 |
Why?
|
| Lymphangioma | 1 | 2000 | 60 | 0.040 |
Why?
|
| Aorta | 4 | 2022 | 2043 | 0.040 |
Why?
|
| Registries | 1 | 2016 | 8352 | 0.040 |
Why?
|
| Recovery of Function | 1 | 2010 | 2978 | 0.040 |
Why?
|
| Infant, Newborn | 20 | 2023 | 26387 | 0.040 |
Why?
|
| Aging | 2 | 1996 | 8728 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2010 | 2645 | 0.040 |
Why?
|
| Vascular Patency | 1 | 2003 | 915 | 0.040 |
Why?
|
| Tricuspid Valve Stenosis | 2 | 1976 | 26 | 0.040 |
Why?
|
| Animals | 20 | 2016 | 168939 | 0.040 |
Why?
|
| Blood Chemical Analysis | 1 | 2021 | 434 | 0.040 |
Why?
|
| Subarachnoid Space | 1 | 1999 | 78 | 0.040 |
Why?
|
| Cobalt Radioisotopes | 1 | 1999 | 75 | 0.040 |
Why?
|
| Dermoid Cyst | 1 | 2000 | 92 | 0.040 |
Why?
|
| Tissue Survival | 1 | 1999 | 120 | 0.040 |
Why?
|
| Research | 1 | 2008 | 1977 | 0.040 |
Why?
|
| Cerebral Amyloid Angiopathy | 1 | 2007 | 887 | 0.040 |
Why?
|
| History, 21st Century | 1 | 2005 | 1574 | 0.040 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 1992 | 2160 | 0.040 |
Why?
|
| Metabolic Clearance Rate | 1 | 1999 | 361 | 0.040 |
Why?
|
| Vena Cava, Inferior | 3 | 2019 | 463 | 0.040 |
Why?
|
| Delivery of Health Care | 3 | 2023 | 5367 | 0.040 |
Why?
|
| Radionuclide Imaging | 2 | 2003 | 1986 | 0.040 |
Why?
|
| Health Facilities | 1 | 2023 | 578 | 0.040 |
Why?
|
| Brain Stem | 2 | 2014 | 858 | 0.040 |
Why?
|
| Genes, Neurofibromatosis 2 | 2 | 2009 | 122 | 0.040 |
Why?
|
| Oxo-Acid-Lyases | 2 | 1988 | 23 | 0.040 |
Why?
|
| Medical History Taking | 1 | 2002 | 779 | 0.040 |
Why?
|
| Immunoblotting | 1 | 2021 | 1647 | 0.040 |
Why?
|
| Abnormalities, Multiple | 2 | 1976 | 1424 | 0.040 |
Why?
|
| Confidence Intervals | 1 | 2004 | 2921 | 0.040 |
Why?
|
| Double-Blind Method | 2 | 2024 | 12430 | 0.040 |
Why?
|
| Situs Inversus | 3 | 1973 | 63 | 0.040 |
Why?
|
| Heart Neoplasms | 1 | 2001 | 374 | 0.040 |
Why?
|
| Occipital Lobe | 1 | 1999 | 376 | 0.040 |
Why?
|
| Academic Medical Centers | 2 | 2019 | 2783 | 0.040 |
Why?
|
| Marfan Syndrome | 1 | 1980 | 237 | 0.040 |
Why?
|
| Hospitals | 2 | 2021 | 3885 | 0.040 |
Why?
|
| Heart Valve Diseases | 1 | 1985 | 1029 | 0.040 |
Why?
|
| Photons | 1 | 2001 | 591 | 0.040 |
Why?
|
| Teratoma | 1 | 2000 | 405 | 0.040 |
Why?
|
| Quality Indicators, Health Care | 1 | 2007 | 1804 | 0.040 |
Why?
|
| Data Interpretation, Statistical | 3 | 2014 | 2694 | 0.040 |
Why?
|
| Time and Motion Studies | 1 | 2017 | 143 | 0.040 |
Why?
|
| Syndrome | 3 | 2020 | 3271 | 0.040 |
Why?
|
| Mortality | 1 | 2008 | 2908 | 0.040 |
Why?
|
| Chorea | 1 | 1998 | 80 | 0.040 |
Why?
|
| Linear Models | 1 | 2007 | 5873 | 0.030 |
Why?
|
| Security Measures | 1 | 2017 | 83 | 0.030 |
Why?
|
| Anisotropy | 1 | 2020 | 1286 | 0.030 |
Why?
|
| Heart | 5 | 1992 | 4425 | 0.030 |
Why?
|
| Incidence | 5 | 2015 | 21527 | 0.030 |
Why?
|
| Aortic Rupture | 1 | 1980 | 322 | 0.030 |
Why?
|
| Vitamin K 1 | 1 | 1996 | 47 | 0.030 |
Why?
|
| Paraneoplastic Syndromes | 1 | 1998 | 154 | 0.030 |
Why?
|
| Dura Mater | 1 | 1998 | 292 | 0.030 |
Why?
|
| Pulmonary Valve Stenosis | 6 | 1976 | 164 | 0.030 |
Why?
|
| Patients | 1 | 2022 | 908 | 0.030 |
Why?
|
| Placebos | 1 | 2020 | 1659 | 0.030 |
Why?
|
| Sulfotransferases | 1 | 1996 | 150 | 0.030 |
Why?
|
| Kidney Neoplasms | 1 | 1993 | 4282 | 0.030 |
Why?
|
| Quality Improvement | 3 | 2017 | 3850 | 0.030 |
Why?
|
| Prostheses and Implants | 1 | 2023 | 1275 | 0.030 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2018 | 638 | 0.030 |
Why?
|
| Neurosciences | 1 | 2000 | 384 | 0.030 |
Why?
|
| Neurosurgical Procedures | 1 | 2006 | 2077 | 0.030 |
Why?
|
| Food, Fortified | 1 | 1996 | 189 | 0.030 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2001 | 1196 | 0.030 |
Why?
|
| Cardiomegaly | 5 | 1982 | 591 | 0.030 |
Why?
|
| Immunoglobulins | 2 | 2001 | 853 | 0.030 |
Why?
|
| Urban Health | 1 | 2017 | 532 | 0.030 |
Why?
|
| Evoked Potentials | 1 | 2000 | 1050 | 0.030 |
Why?
|
| Survival Rate | 4 | 2013 | 12826 | 0.030 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2018 | 878 | 0.030 |
Why?
|
| Telephone | 1 | 2017 | 629 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2004 | 10101 | 0.030 |
Why?
|
| Memory Disorders | 1 | 2021 | 1193 | 0.030 |
Why?
|
| Miniaturization | 1 | 2014 | 151 | 0.030 |
Why?
|
| Organizational Innovation | 1 | 2017 | 540 | 0.030 |
Why?
|
| Patient Transfer | 1 | 2021 | 789 | 0.030 |
Why?
|
| Plasmapheresis | 1 | 2014 | 205 | 0.030 |
Why?
|
| Cardiac Pacing, Artificial | 2 | 1991 | 881 | 0.030 |
Why?
|
| Fluorocarbons | 1 | 1999 | 498 | 0.030 |
Why?
|
| Microwaves | 1 | 1995 | 183 | 0.030 |
Why?
|
| Hospitalization | 1 | 2013 | 10816 | 0.030 |
Why?
|
| Earache | 1 | 2013 | 14 | 0.030 |
Why?
|
| Nerve Fibers, Myelinated | 2 | 2009 | 951 | 0.030 |
Why?
|
| Hematologic Tests | 1 | 2014 | 239 | 0.030 |
Why?
|
| Outpatients | 1 | 2021 | 1596 | 0.030 |
Why?
|
| Writing | 1 | 2015 | 200 | 0.030 |
Why?
|
| Multicenter Studies as Topic | 1 | 2018 | 1733 | 0.030 |
Why?
|
| Brain Chemistry | 1 | 1996 | 951 | 0.030 |
Why?
|
| Tachycardia, Atrioventricular Nodal Reentry | 1 | 1994 | 148 | 0.030 |
Why?
|
| Length of Stay | 2 | 2019 | 6491 | 0.030 |
Why?
|
| Bundle-Branch Block | 1 | 1975 | 280 | 0.030 |
Why?
|
| Patient Care Planning | 1 | 1998 | 904 | 0.030 |
Why?
|
| Consensus Development Conferences as Topic | 1 | 2013 | 168 | 0.030 |
Why?
|
| Lymphatic Metastasis | 1 | 2000 | 2901 | 0.030 |
Why?
|
| Evidence-Based Practice | 1 | 2017 | 499 | 0.030 |
Why?
|
| Biomedical Research | 1 | 2008 | 3459 | 0.030 |
Why?
|
| Spine | 1 | 2019 | 1134 | 0.030 |
Why?
|
| Antibodies, Anticardiolipin | 1 | 1992 | 62 | 0.020 |
Why?
|
| Efficiency, Organizational | 1 | 2017 | 695 | 0.020 |
Why?
|
| Methods | 4 | 1980 | 1065 | 0.020 |
Why?
|
| Natural Language Processing | 1 | 2021 | 1203 | 0.020 |
Why?
|
| Foreign-Body Reaction | 1 | 1992 | 156 | 0.020 |
Why?
|
| Dextrocardia | 2 | 1969 | 37 | 0.020 |
Why?
|
| Biopsy | 1 | 2004 | 6779 | 0.020 |
Why?
|
| Hearing Loss, Conductive | 1 | 2013 | 159 | 0.020 |
Why?
|
| Respirovirus | 2 | 2001 | 31 | 0.020 |
Why?
|
| Reference Values | 2 | 1997 | 4914 | 0.020 |
Why?
|
| Anticonvulsants | 1 | 2021 | 1921 | 0.020 |
Why?
|
| Regression Analysis | 3 | 2009 | 6329 | 0.020 |
Why?
|
| Natural Cytotoxicity Triggering Receptor 1 | 2 | 2001 | 29 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2014 | 1805 | 0.020 |
Why?
|
| Equipment Failure Analysis | 1 | 2014 | 832 | 0.020 |
Why?
|
| Decision Trees | 1 | 2013 | 508 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2014 | 958 | 0.020 |
Why?
|
| Electric Impedance | 1 | 2016 | 791 | 0.020 |
Why?
|
| Dexamethasone | 1 | 1999 | 1962 | 0.020 |
Why?
|
| Neural Pathways | 2 | 2020 | 3079 | 0.020 |
Why?
|
| Pulmonary Valve | 2 | 1994 | 413 | 0.020 |
Why?
|
| Rats, Inbred F344 | 1 | 1992 | 820 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2020 | 3681 | 0.020 |
Why?
|
| Vaccination | 1 | 2023 | 3435 | 0.020 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 1999 | 1536 | 0.020 |
Why?
|
| Vascular Surgical Procedures | 1 | 1999 | 1506 | 0.020 |
Why?
|
| Injections, Intravenous | 2 | 2005 | 1377 | 0.020 |
Why?
|
| Databases, Factual | 2 | 2018 | 8065 | 0.020 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2020 | 2419 | 0.020 |
Why?
|
| Mitral Valve | 3 | 1983 | 1473 | 0.020 |
Why?
|
| Echocardiography | 4 | 1989 | 5038 | 0.020 |
Why?
|
| Washington | 1 | 2010 | 315 | 0.020 |
Why?
|
| Glasgow Coma Scale | 1 | 2011 | 574 | 0.020 |
Why?
|
| Ebstein Anomaly | 1 | 1970 | 106 | 0.020 |
Why?
|
| Models, Animal | 1 | 2016 | 2121 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2022 | 3618 | 0.020 |
Why?
|
| Aortic Stenosis, Subvalvular | 1 | 1989 | 10 | 0.020 |
Why?
|
| Supratentorial Neoplasms | 2 | 2001 | 156 | 0.020 |
Why?
|
| Anthropometry | 1 | 1974 | 1336 | 0.020 |
Why?
|
| Brain Damage, Chronic | 1 | 2010 | 265 | 0.020 |
Why?
|
| Quality Assurance, Health Care | 1 | 1999 | 2171 | 0.020 |
Why?
|
| Radio | 1 | 1988 | 9 | 0.020 |
Why?
|
| Jugular Veins | 1 | 2010 | 211 | 0.020 |
Why?
|
| Audiometry, Pure-Tone | 1 | 2009 | 210 | 0.020 |
Why?
|
| Occupational Health | 1 | 2015 | 812 | 0.020 |
Why?
|
| Radiation | 1 | 1988 | 48 | 0.020 |
Why?
|
| Acetabulum | 1 | 1992 | 543 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 1997 | 6214 | 0.020 |
Why?
|
| Glycosphingolipids | 1 | 1988 | 72 | 0.020 |
Why?
|
| Pulmonary Veins | 2 | 1981 | 759 | 0.020 |
Why?
|
| Neurofibromin 2 | 1 | 2009 | 269 | 0.020 |
Why?
|
| International Normalized Ratio | 1 | 2010 | 382 | 0.020 |
Why?
|
| Communication | 1 | 2022 | 3905 | 0.020 |
Why?
|
| Hospitals, University | 1 | 2010 | 572 | 0.020 |
Why?
|
| International Classification of Diseases | 1 | 2014 | 935 | 0.020 |
Why?
|
| Receptors, IgG | 2 | 2001 | 562 | 0.020 |
Why?
|
| Validation Studies as Topic | 1 | 2008 | 162 | 0.020 |
Why?
|
| Drug Hypersensitivity | 1 | 2016 | 903 | 0.020 |
Why?
|
| Aortic Valve | 3 | 1989 | 1966 | 0.020 |
Why?
|
| Oculomotor Nerve | 1 | 2007 | 72 | 0.020 |
Why?
|
| Chronic Disease | 3 | 2013 | 9358 | 0.020 |
Why?
|
| Cranial Nerves | 1 | 2007 | 97 | 0.020 |
Why?
|
| Prosthesis Failure | 1 | 1992 | 1208 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 1997 | 10745 | 0.020 |
Why?
|
| Mice | 5 | 2016 | 81898 | 0.020 |
Why?
|
| Tetralogy of Fallot | 3 | 1982 | 628 | 0.020 |
Why?
|
| Endocardium | 1 | 1968 | 249 | 0.020 |
Why?
|
| Desiccation | 1 | 1987 | 77 | 0.020 |
Why?
|
| Spleen | 4 | 1976 | 2295 | 0.020 |
Why?
|
| Postoperative Complications | 2 | 2006 | 15831 | 0.020 |
Why?
|
| Neurologic Examination | 1 | 2009 | 913 | 0.020 |
Why?
|
| Autopsy | 5 | 1974 | 1011 | 0.020 |
Why?
|
| Trigeminal Nerve | 1 | 2007 | 248 | 0.020 |
Why?
|
| Hemodynamics | 3 | 2002 | 4188 | 0.020 |
Why?
|
| Dementia, Vascular | 1 | 2007 | 126 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 1999 | 5536 | 0.020 |
Why?
|
| Cerebellum | 1 | 2013 | 1520 | 0.020 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2009 | 792 | 0.020 |
Why?
|
| Movement Disorders | 1 | 2009 | 462 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1996 | 8108 | 0.020 |
Why?
|
| Fever | 1 | 2013 | 1607 | 0.020 |
Why?
|
| Craniotomy | 1 | 2009 | 736 | 0.020 |
Why?
|
| Phospholipids | 1 | 1988 | 778 | 0.010 |
Why?
|
| Risk | 1 | 2017 | 9602 | 0.010 |
Why?
|
| Radiographic Magnification | 1 | 2004 | 18 | 0.010 |
Why?
|
| Confusion | 1 | 2006 | 278 | 0.010 |
Why?
|
| Dementia | 1 | 1999 | 2741 | 0.010 |
Why?
|
| Vasodilator Agents | 1 | 2008 | 988 | 0.010 |
Why?
|
| Nanoparticles | 1 | 2016 | 1966 | 0.010 |
Why?
|
| Veins | 1 | 1988 | 769 | 0.010 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2018 | 2429 | 0.010 |
Why?
|
| Genotype | 2 | 2009 | 13036 | 0.010 |
Why?
|
| Heart Valves | 2 | 1976 | 284 | 0.010 |
Why?
|
| Patient Discharge | 1 | 2016 | 3466 | 0.010 |
Why?
|
| Creatinine | 1 | 2009 | 1917 | 0.010 |
Why?
|
| User-Computer Interface | 1 | 2010 | 1409 | 0.010 |
Why?
|
| Transfection | 2 | 2001 | 5755 | 0.010 |
Why?
|
| Rats | 2 | 1996 | 23717 | 0.010 |
Why?
|
| Apolipoprotein E4 | 1 | 2007 | 709 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2001 | 3738 | 0.010 |
Why?
|
| Lymph | 1 | 1982 | 78 | 0.010 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2016 | 2306 | 0.010 |
Why?
|
| Disability Evaluation | 1 | 2009 | 1828 | 0.010 |
Why?
|
| Vision Disorders | 1 | 2009 | 1090 | 0.010 |
Why?
|
| Tumor Burden | 1 | 2008 | 1902 | 0.010 |
Why?
|
| Lung | 1 | 2021 | 10068 | 0.010 |
Why?
|
| Natural Cytotoxicity Triggering Receptor 2 | 1 | 2001 | 2 | 0.010 |
Why?
|
| Natural Cytotoxicity Triggering Receptor 3 | 1 | 2001 | 14 | 0.010 |
Why?
|
| Quality of Health Care | 1 | 2017 | 4306 | 0.010 |
Why?
|
| Microcirculation | 1 | 2006 | 1282 | 0.010 |
Why?
|
| Guidelines as Topic | 1 | 2008 | 1394 | 0.010 |
Why?
|
| Pulmonary Circulation | 2 | 1975 | 744 | 0.010 |
Why?
|
| Organ Size | 2 | 1980 | 2262 | 0.010 |
Why?
|
| Benchmarking | 1 | 2008 | 1056 | 0.010 |
Why?
|
| Sialic Acids | 1 | 2001 | 122 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2014 | 4215 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2018 | 10384 | 0.010 |
Why?
|
| Quality Control | 1 | 2004 | 834 | 0.010 |
Why?
|
| Point-of-Care Systems | 1 | 2010 | 1217 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2008 | 2721 | 0.010 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2019 | 5389 | 0.010 |
Why?
|
| Preoperative Care | 1 | 2009 | 2253 | 0.010 |
Why?
|
| N-Acetylneuraminic Acid | 1 | 2001 | 174 | 0.010 |
Why?
|
| Recurrence | 1 | 2013 | 8507 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2014 | 7841 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 2001 | 861 | 0.010 |
Why?
|
| Ultrasonography | 1 | 1993 | 5990 | 0.010 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 1989 | 1337 | 0.010 |
Why?
|
| Sex Factors | 2 | 2009 | 10619 | 0.010 |
Why?
|
| Actuarial Analysis | 1 | 1999 | 370 | 0.010 |
Why?
|
| Karnofsky Performance Status | 1 | 1999 | 163 | 0.010 |
Why?
|
| Arrhythmias, Cardiac | 1 | 1989 | 2257 | 0.010 |
Why?
|
| Mental Disorders | 1 | 1999 | 6869 | 0.010 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2001 | 287 | 0.010 |
Why?
|
| Supine Position | 1 | 1999 | 208 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2010 | 9661 | 0.010 |
Why?
|
| Carotid Artery, Common | 1 | 1999 | 172 | 0.010 |
Why?
|
| Clone Cells | 1 | 2001 | 1670 | 0.010 |
Why?
|
| Guideline Adherence | 1 | 2008 | 2233 | 0.010 |
Why?
|
| Internet | 1 | 2010 | 3113 | 0.010 |
Why?
|
| Central Nervous System Diseases | 1 | 2001 | 518 | 0.010 |
Why?
|
| Angiography, Digital Subtraction | 1 | 1998 | 331 | 0.010 |
Why?
|
| Stents | 1 | 2008 | 3193 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 1988 | 4525 | 0.010 |
Why?
|
| Body Height | 2 | 1974 | 1562 | 0.010 |
Why?
|
| Cost Savings | 1 | 2001 | 903 | 0.010 |
Why?
|
| Hemiplegia | 1 | 1996 | 137 | 0.010 |
Why?
|
| Antibodies, Bacterial | 1 | 1981 | 1477 | 0.010 |
Why?
|
| Capillary Permeability | 1 | 1999 | 772 | 0.010 |
Why?
|
| Electrodes | 2 | 1988 | 612 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2019 | 13489 | 0.010 |
Why?
|
| Aortic Aneurysm | 1 | 1980 | 649 | 0.010 |
Why?
|
| Energy Transfer | 1 | 1995 | 108 | 0.010 |
Why?
|
| Posture | 1 | 1999 | 955 | 0.010 |
Why?
|
| Metals | 1 | 1999 | 711 | 0.010 |
Why?
|
| Radiotherapy Dosage | 1 | 2001 | 2916 | 0.010 |
Why?
|
| Angiocardiography | 2 | 1971 | 149 | 0.010 |
Why?
|
| Cardiac Complexes, Premature | 1 | 1994 | 63 | 0.010 |
Why?
|
| Ligands | 1 | 2001 | 3274 | 0.010 |
Why?
|
| Blood Circulation | 1 | 1975 | 248 | 0.010 |
Why?
|
| Blood Pressure | 2 | 1974 | 8533 | 0.010 |
Why?
|
| Lymphoma, Follicular | 1 | 1997 | 460 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2001 | 6105 | 0.010 |
Why?
|
| Azygos Vein | 1 | 1973 | 19 | 0.010 |
Why?
|
| Cognition Disorders | 1 | 2007 | 3967 | 0.010 |
Why?
|
| Hepatic Veins | 1 | 1973 | 112 | 0.010 |
Why?
|
| Reserpine | 1 | 1992 | 63 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2001 | 6225 | 0.010 |
Why?
|
| Body Weight | 2 | 1974 | 4626 | 0.010 |
Why?
|
| Specific Gravity | 1 | 1971 | 18 | 0.010 |
Why?
|
| Isoproterenol | 1 | 1992 | 398 | 0.010 |
Why?
|
| Body Temperature | 1 | 1995 | 780 | 0.010 |
Why?
|
| Mitral Valve Stenosis | 2 | 1970 | 342 | 0.010 |
Why?
|
| Phenotype | 1 | 2009 | 16722 | 0.010 |
Why?
|
| Heart Rate | 1 | 1983 | 4207 | 0.010 |
Why?
|
| Bacteria | 1 | 1981 | 2212 | 0.010 |
Why?
|
| Portal Vein | 1 | 1973 | 437 | 0.010 |
Why?
|
| Mathematics | 1 | 1971 | 696 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 2001 | 3213 | 0.010 |
Why?
|
| Coronary Vessel Anomalies | 1 | 1973 | 308 | 0.010 |
Why?
|
| Congenital Abnormalities | 1 | 1974 | 703 | 0.000 |
Why?
|
| Models, Theoretical | 1 | 2001 | 3563 | 0.000 |
Why?
|
| Crohn Disease | 1 | 1981 | 2286 | 0.000 |
Why?
|
| Coronary Circulation | 1 | 1975 | 1602 | 0.000 |
Why?
|
| Protein Binding | 1 | 2001 | 9326 | 0.000 |
Why?
|
| Heart Function Tests | 1 | 1969 | 315 | 0.000 |
Why?
|
| Hot Temperature | 1 | 1995 | 1441 | 0.000 |
Why?
|
| Pulse | 1 | 1968 | 217 | 0.000 |
Why?
|
| Poliomyelitis | 1 | 1948 | 91 | 0.000 |
Why?
|
| Cell Line | 1 | 2001 | 15564 | 0.000 |
Why?
|
| Fibrosis | 1 | 1994 | 2078 | 0.000 |
Why?
|
| Atrophy | 1 | 1971 | 1631 | 0.000 |
Why?
|
| Alzheimer Disease | 1 | 2007 | 8715 | 0.000 |
Why?
|
| Cross-Sectional Studies | 1 | 1985 | 26309 | 0.000 |
Why?
|
| Fluoroscopy | 1 | 1988 | 948 | 0.000 |
Why?
|
| L Forms | 1 | 1981 | 1 | 0.000 |
Why?
|
| Catheterization | 1 | 1987 | 1429 | 0.000 |
Why?
|
| Bacteroides | 1 | 1981 | 165 | 0.000 |
Why?
|
| Central Nervous System | 1 | 1948 | 1345 | 0.000 |
Why?
|
| Heart Septal Defects | 1 | 1982 | 191 | 0.000 |
Why?
|
| Pregnancy | 2 | 1975 | 30236 | 0.000 |
Why?
|
| Vena Cava, Superior | 1 | 1981 | 197 | 0.000 |
Why?
|
| Quality of Life | 1 | 2001 | 13476 | 0.000 |
Why?
|
| Cross Reactions | 1 | 1981 | 826 | 0.000 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1981 | 2470 | 0.000 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 1981 | 361 | 0.000 |
Why?
|
| Models, Biological | 1 | 1971 | 9464 | 0.000 |
Why?
|
| Pseudomonas aeruginosa | 1 | 1981 | 1276 | 0.000 |
Why?
|
| Colon | 1 | 1981 | 1797 | 0.000 |
Why?
|
| Cineangiography | 1 | 1970 | 108 | 0.000 |
Why?
|
| Colitis, Ulcerative | 1 | 1981 | 1920 | 0.000 |
Why?
|
| Escherichia coli | 1 | 1981 | 4211 | 0.000 |
Why?
|
| Pedigree | 1 | 1970 | 4539 | 0.000 |
Why?
|
| Cardiac Surgical Procedures | 1 | 1970 | 3683 | 0.000 |
Why?
|
| Heart Failure | 1 | 1970 | 11879 | 0.000 |
Why?
|